SCHEMBL4582234

SCHEMBL4582234

Cn1cc(-c2ccc(C(N)=O)c(NCC3CCCO3)c2)c2c1C(=O)CC(C)(C)C2

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 12/20 0.45
ALDH1A1 P00352 3/20 0.43
HPGD P15428 2/20 0.43
MAPK1 P28482 1/20 0.43
HSP90AB1 P08238 11/20 0.42
HSP90B1 P14625 7/20 0.42
TRAP1 Q12931 7/20 0.42
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
GAA P10253 2/20 0.40
KMT2A Q03164 1/20 0.40
AURKA O14965 1/20 0.37
RPS6KB1 P23443 1/20 0.37
SHMT2 P34897 1/20 0.37
KDM4E B2RXH2 1/20 0.35
CASP1 P29466 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4580008 0.85 ALDH1A1 (0.42) ALDH1A1HPGDMAPK1HSD17B10TSHR
SCHEMBL4580533 0.80 HSP90AA1 (0.56) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL1219528 0.75 HSP90AA1 (0.64) HSP90AA1ALDH1A1HSP90AB1HSP90B1TRAP1
SCHEMBL1220784 0.73 HSP90AA1 (0.68) HSP90AA1ALDH1A1HSP90AB1HSP90B1TRAP1
SCHEMBL1219504 0.73 HSP90AA1 (0.68) HSP90AA1ALDH1A1HSP90AB1HSP90B1TRAP1
SCHEMBL1220613 0.73 HSP90AA1 (0.68) HSP90AA1ALDH1A1HSP90AB1HSP90B1TRAP1
Benzamide SCHEMBL27649723 0.71 HSP90AA1 (0.61) HSP90AA1HSP90AB1HSP90B1TRAP1
SCHEMBL2429345 0.69 HCAR3 (0.62) HSP90AA1ALDH1A1HPGDHSD17B10TSHR
Benzamide SCHEMBL28758807 0.69 HSP90AA1 (0.62) HSP90AA1ALDH1A1HSP90AB1HSP90B1TRAP1
SCHEMBL4581631 0.67 HSP90AA1 (0.39) HSP90AA1HSP90AB1HSP90B1TRAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080119457-A1 Benzene, Pyridine, and Pyridazine Derivatives SERENEX, INC. 2008-05-22 US disclosed
US-20080119457-A1 Benzene, Pyridine, and Pyridazine Derivatives SERENEX, INC. 2008-05-22 US disclosed
US-20080119457-A1 Benzene, Pyridine, and Pyridazine Derivatives SERENEX, INC. 2008-05-22 US disclosed
WO-2008024978-A2 TETRAHYDROINDOLONE AND TETRAHYDROINDAZOLONE DERIVATIVES SERENEX, INC. (US) 2008-02-28 WO disclosed
WO-2008024978-A2 TETRAHYDROINDOLONE AND TETRAHYDROINDAZOLONE DERIVATIVES SERENEX, INC. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119457-A1 Benzene, Pyridine, and Pyridazine Derivatives MKI67, CCNB1, RB1 HSP90AA1 2260/4885ALDH1A1 440/4885HPGD 654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.